Royal Caribbean Earnings Beat, Revenue Outlook Trimmed

Royal Caribbean earnings beat and raised adjusted EPS guidance while trimming revenue growth after geopolitical booking headwinds, prompting trader reassessments.

July 28, 2026·2 min read
View all news articles
Flat vector of a cruise ship hull with a tightening band symbolizing Royal Caribbean earnings, margins, and booking pressure.

KEY TAKEAWAYS

  • Royal Caribbean beat Q2 adjusted EPS at $4.21 and raised full-year adjusted EPS guidance to $17.73-$17.87.
  • Trimmed full-year revenue growth to about 9.0% from about 10.0% after geopolitical activity pressured select itineraries.
  • Results reflected stronger close-in demand, record prices, robust load factors and $1.8 billion of adjusted EBITDA.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Royal Caribbean Group said in a press release on July 28, 2026, that it beat second-quarter profit estimates and raised full-year adjusted EPS guidance while trimming its revenue outlook after geopolitical tensions pressured cruise bookings.

Earnings Beat and Guidance

For the quarter ended June 30, 2026, Royal Caribbean reported adjusted EPS of $4.21 and GAAP EPS of $4.20, both above analyst consensus near $3.98. Adjusted EBITDA, a proxy for operating profit, reached $1.8 billion. The company raised full-year adjusted EPS guidance to $17.73–$17.87 from $17.10–$17.50 and set third-quarter adjusted EPS guidance at $6.26–$6.36. Management attributed the outperformance to strong close-in demand, lower costs, and favorable joint-venture results, which supported margins and the updated earnings outlook.

Revenue Outlook Trimmed Amid Booking Pressure

Royal Caribbean reported quarterly revenue between $4.8 billion and $4.83 billion, up about 6% year over year, but trimmed its full-year revenue growth target to about 9% from about 10%. The company said cruise bookings remain strong, with record prices, booking volumes above last year, and robust load factors. However, prolonged geopolitical activity caused a modest near-term impact on bookings for select itineraries.

This combination of strong pricing and load factors alongside itinerary-specific booking softness explains why management raised its profit forecast even as it lowered its top-line growth projection. Operationally, near-term revenue headwinds tied to geopolitical disruptions are limited in scope, while cost reductions and joint-venture returns have expanded the margin cushion supporting the new guidance.

Investors will monitor future booking trends and close-in demand to assess whether the company can sustain margin gains even if revenue growth falls slightly short of earlier expectations.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Super Micro Earnings Preview: Margins and Backlog

Super Micro Earnings Preview: Margins and Backlog

Super Micro earnings preview noted 15%-17% gross margin and a record backlog, putting traders on watch for backlog conversion into revenue and AI demand.

Trump Media Earnings: Q2 Loss Deepens

Trump Media Earnings: Q2 Loss Deepens

Trump Media earnings said non-cash digital-asset writedowns pushed $238.1 million Q2 loss, magnifying asset-price volatility and prompting traders to trim stakes.

Nvidia $500 Billion AI Financing Deal

Nvidia $500 Billion AI Financing Deal

Nvidia $500 billion AI financing pact with six Wall Street firms aims to mobilize capital for compute and data centers and could reprice chip demand.

Hims & Hers Q2 2026 Results: Guidance Raised

Hims & Hers Q2 2026 Results: Guidance Raised

Hims & Hers Q2 2026 Results lifted full-year revenue and adjusted-EBITDA guidance after subscriber gains, sharpening trader focus on growth versus margins.

AbCellera ABCL635 Phase 2 Results Lift Shares

AbCellera ABCL635 Phase 2 Results Lift Shares

AbCellera ABCL635 Phase 2 Results showed the drug met primary endpoints cutting hot flash frequency and severity and prompting a 24% stock rise.

Nebius Earnings Preview: Q1 Surge, Financing Risk

Nebius Earnings Preview: Q1 Surge, Financing Risk

Nebius earnings draw trader focus as Q2 nears; Q1 revenue of $399M and $1.9B ARR face heavy costs and a high-profile short raising financing and flow risk.